{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:30Z","timestamp":1761058650835},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4-5","license":[{"start":{"date-parts":[[2007,3,7]],"date-time":"2007-03-07T00:00:00Z","timestamp":1173225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2007,3,22]]},"DOI":"10.1007\/s11064-007-9296-y","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T22:13:27Z","timestamp":1173219207000},"page":"717-722","source":"Crossref","is-referenced-by-count":19,"title":["Indices of Metabolic Dysfunction and Oxidative Stress"],"prefix":"10.1007","volume":"32","author":[{"given":"Gemma","family":"Casadesus","sequence":"first","affiliation":[]},{"given":"Paula I.","family":"Moreira","sequence":"additional","affiliation":[]},{"given":"Akihiko","family":"Nunomura","sequence":"additional","affiliation":[]},{"given":"Sandra L.","family":"Siedlak","sequence":"additional","affiliation":[]},{"given":"William","family":"Bligh-Glover","sequence":"additional","affiliation":[]},{"given":"Elizabeth","family":"Balraj","sequence":"additional","affiliation":[]},{"given":"Grace","family":"Petot","sequence":"additional","affiliation":[]},{"given":"Mark A.","family":"Smith","sequence":"additional","affiliation":[]},{"given":"George","family":"Perry","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,3,7]]},"reference":[{"key":"9296_CR1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"9296_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u2013185","journal-title":"Science"},{"key":"9296_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","volume":"3","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3:75\u201380","journal-title":"J Alzheimers Dis"},{"key":"9296_CR4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-1999-14-510","volume":"1","author":"JQ Trojanowski","year":"1999","unstructured":"Trojanowski JQ, Clark CM, Arai H, Lee VM (1999) Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer\u2019s disease. J Alzheimers Dis 1:297\u2013305","journal-title":"J Alzheimers Dis"},{"key":"9296_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.55782\/ane-2004-1489","volume":"64","author":"A Gomez-Ramos","year":"2004","unstructured":"Gomez-Ramos A, Smith MA, Perry G, Avila J (2004) Tau phosphorylation and assembly. Acta Neurobiol Exp (Wars) 64:33\u201339","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"9296_CR6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-006-0071-y","volume":"111","author":"RJ Castellani","year":"2006","unstructured":"Castellani RJ, Lee HG, Zhu X, Nunomura A, Perry G, Smith MA (2006) Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. Acta Neuropathol (Berl) 111:503\u2013509","journal-title":"Acta Neuropathol (Berl)"},{"key":"9296_CR7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmed.2005.02.008","volume":"11","author":"HG Lee","year":"2005","unstructured":"Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, Takeda A, Nunomura A, Smith MA (2005) Tau phosphorylation in Alzheimer\u2019s disease: pathogen or protector? Trends Mol Med 11:164\u2013169","journal-title":"Trends Mol Med"},{"key":"9296_CR8","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0891-5849(02)01021-3","volume":"33","author":"MA Smith","year":"2002","unstructured":"Smith MA, Casadesus G, Joseph JA, Perry G (2002) Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 33:1194\u20131199","journal-title":"Free Radic Biol Med"},{"key":"9296_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-1998-1103","volume":"1","author":"G Perry","year":"1998","unstructured":"Perry G, Castellani RJ, Hirai K, Smith MA (1998) Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimers Dis 1:45\u201355","journal-title":"J Alzheimers Dis"},{"key":"9296_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1474-4422(04)00707-0","volume":"3","author":"X Zhu","year":"2004","unstructured":"Zhu X, Raina AK, Perry G, Smith MA (2004) Alzheimer\u2019s disease: the two-hit hypothesis. Lancet Neurol 3:219\u2013226","journal-title":"Lancet Neurol"},{"key":"9296_CR11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2004.06.003","volume":"17","author":"A Nunomura","year":"2004","unstructured":"Nunomura A, Chiba S, Lippa CF, Cras P, Kalaria RN, Takeda A, Honda K, Smith MA, Perry G (2004) Neuronal RNA oxidation is a prominent feature of familial Alzheimer\u2019s disease. Neurobiol Dis 17:108\u2013113","journal-title":"Neurobiol Dis"},{"key":"9296_CR12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759\u2013767","journal-title":"J Neuropathol Exp Neurol"},{"key":"9296_CR13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jnen\/59.11.1011","volume":"59","author":"A Nunomura","year":"2000","unstructured":"Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, Smith MA (2000) Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol 59:1011\u20131017","journal-title":"J Neuropathol Exp Neurol"},{"key":"9296_CR14","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","volume":"19","author":"A Nunomura","year":"1999","unstructured":"Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease. J Neurosci 19:1959\u20131964","journal-title":"J Neurosci"},{"key":"9296_CR15","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","volume":"94","author":"MA Smith","year":"1997","unstructured":"Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94:9866\u20139868","journal-title":"Proc Natl Acad Sci USA"},{"key":"9296_CR16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1471-4159.2000.0740270.x","volume":"74","author":"LM Sayre","year":"2000","unstructured":"Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease: a central role for bound transition metals. J Neurochem 74:270\u2013279","journal-title":"J Neurochem"},{"key":"9296_CR17","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer\u2019s disease. J Neurosci 21:3017\u20133023","journal-title":"J Neurosci"},{"key":"9296_CR18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1749-6632.2000.tb06370.x","volume":"903","author":"JP Blass","year":"2000","unstructured":"Blass JP, Sheu RK, Gibson GE (2000) Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann N Y Acad Sci 903:204\u2013221","journal-title":"Ann N Y Acad Sci"},{"key":"9296_CR19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.410350311","volume":"35","author":"KF Sheu","year":"1994","unstructured":"Sheu KF, Cooper AJ, Koike K, Koike M, Lindsay JG, Blass JP (1994) Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer\u2019s disease. Ann Neurol 35:312\u2013318","journal-title":"Ann Neurol"},{"key":"9296_CR20","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1073\/pnas.93.7.2719","volume":"93","author":"M Hoshi","year":"1996","unstructured":"Hoshi M, Takashima A, Noguchi K, Murayama M, Sato M, Kondo S, Saitoh Y, Ishiguro K, Hoshino T, Imahori K (1996) Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I\/glycogen synthase kinase 3beta in brain. Proc Natl Acad Sci USA 93:2719\u20132723","journal-title":"Proc Natl Acad Sci USA"},{"key":"9296_CR21","first-page":"9","volume":"14","author":"GW Small","year":"1996","unstructured":"Small GW (1996) Neuroimaging and genetic assessment for early diagnosis of Alzheimer\u2019s disease. J Clin Psychiatry 57 Suppl 14:9\u201313","journal-title":"J Clin Psychiatry"},{"key":"9296_CR22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","volume":"30","author":"A Drzezga","year":"2003","unstructured":"Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30:1104\u20131113","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9296_CR23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jnnp.2003.014993","volume":"75","author":"L Mosconi","year":"2004","unstructured":"Mosconi L, Nacmias B, Sorbi S, De Cristofaro MT, Fayazz M, Tedde A, Bracco L, Herholz K, Pupi A (2004) Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 75:370\u2013376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9296_CR24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","volume":"101","author":"EM Reiman","year":"2004","unstructured":"Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia. Proc Natl Acad Sci USA 101:284\u2013289","journal-title":"Proc Natl Acad Sci USA"},{"key":"9296_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0006-8993(98)00006-7","volume":"791","author":"G Perry","year":"1998","unstructured":"Perry G, Smith MA, McCann CE, Siedlak SL, Jones PK, Friedland RP (1998) Cerebrovascular muscle atrophy is a feature of Alzheimer\u2019s disease. Brain Res 791:63\u201366","journal-title":"Brain Res"},{"key":"9296_CR26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ana.410240610","volume":"24","author":"RN Kalaria","year":"1988","unstructured":"Kalaria RN, Gravina SA, Schmidley JW, Perry G, Harik SI (1988) The glucose transporter of the human brain and blood-brain barrier. Ann Neurol 24:757\u2013764","journal-title":"Ann Neurol"},{"key":"9296_CR27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.20799","volume":"59","author":"W Jagust","year":"2006","unstructured":"Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M (2006) Brain imaging evidence of preclinical Alzheimer\u2019s disease in normal aging. Ann Neurol 59:673\u2013681","journal-title":"Ann Neurol"},{"key":"9296_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3233\/JAD-2001-3406","volume":"3","author":"RN Martins","year":"2001","unstructured":"Martins RN (2001) Amyloid beta protein precursor metabolism as a modulator of islet beta-cell function. J Alzheimers Dis 3:397\u2013399","journal-title":"J Alzheimers Dis"},{"key":"9296_CR29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","volume":"9","author":"N Lester-Coll","year":"2006","unstructured":"Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer\u2019s disease. J Alzheimers Dis 9:13\u201333","journal-title":"J Alzheimers Dis"},{"key":"9296_CR30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","volume":"8","author":"EJ Rivera","year":"2005","unstructured":"Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: link to brain reductions in acetylcholine. J Alzheimers Dis 8:247\u2013268","journal-title":"J Alzheimers Dis"},{"key":"9296_CR31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2013is this type 3 diabetes? J Alzheimers Dis 7:63\u201380","journal-title":"J Alzheimers Dis"},{"key":"9296_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","volume":"7","author":"SM la Monte de","year":"2005","unstructured":"de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer\u2019s disease. J Alzheimers Dis 7:45\u201361","journal-title":"J Alzheimers Dis"},{"key":"9296_CR33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","volume":"343","author":"JW Hoppener","year":"2000","unstructured":"Hoppener JW, Ahren B, Lips CJ (2000) Islet amyloid and type 2 diabetes mellitus. N Engl J Med 343:411\u2013419","journal-title":"N Engl J Med"},{"key":"9296_CR34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-7091-7508-8_18","volume":"54","author":"S Hoyer","year":"1998","unstructured":"Hoyer S (1998) Risk factors for Alzheimer\u2019s disease during aging. Impacts of glucose\/energy metabolism. J Neural Transm Suppl 54:187\u2013194","journal-title":"J Neural Transm Suppl"},{"key":"9296_CR35","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1023\/A:1025678510480","volume":"28","author":"G Perry","year":"2003","unstructured":"Perry G, Nunomura A, Raina AK, Aliev G, Siedlak SL, Harris PL, Casadesus G, Petersen RB, Bligh-Glover W, Balraj E, Petot GJ, Smith MA (2003) A metabolic basis for Alzheimer disease. Neurochem Res 28:1549\u20131552","journal-title":"Neurochem Res"},{"key":"9296_CR36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/JAD-1999-14-502","volume":"1","author":"MA Smith","year":"1999","unstructured":"Smith MA, Petot GJ, Perry G (1999) Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer\u2019s disease. J Alzheimers Dis 1:203\u2013206","journal-title":"J Alzheimers Dis"},{"key":"9296_CR37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JAD-1999-14-501","volume":"1","author":"WB Grant","year":"1999","unstructured":"Grant WB (1999) Dietary links to Alzheimer\u2019s disease: 1999 update. J Alzheimers Dis 1:197\u2013201","journal-title":"J Alzheimers Dis"},{"key":"9296_CR38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0140-6736(93)91709-U","volume":"342","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, McCown N et al (1993) Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer\u2019s disease and in other amyloid-forming diseases. Lancet 342:710\u2013711","journal-title":"Lancet"},{"key":"9296_CR39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2004.09.007","volume":"226","author":"GJ Petot","year":"2004","unstructured":"Petot GJ, Friedland RP (2004) Lipids, diet and Alzheimer disease: an extended summary. J Neurol Sci 226:31\u201333","journal-title":"J Neurol Sci"},{"key":"9296_CR40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/archinte.164.1.109-b","volume":"164","author":"WB Grant","year":"2004","unstructured":"Grant WB (2004) Obesity and Alzheimer disease: roles of diet and genetics. Arch Intern Med 164:109\u2013110, author reply 110","journal-title":"Arch Intern Med"},{"key":"9296_CR41","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0002-9440(10)63229-4","volume":"164","author":"W Farris","year":"2004","unstructured":"Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, Eckman CB, Tanzi RE, Selkoe DJ (2004) Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164:1425\u20131434","journal-title":"Am J Pathol"},{"key":"9296_CR42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0306-4530(02)00087-2","volume":"28","author":"S Craft","year":"2003","unstructured":"Craft S, Asthana S, Cook DG, Baker LD, Cherrier M, Purganan K, Wait C, Petrova A, Latendresse S, Watson GS, Newcomer JW, Schellenberg GD, Krohn AJ (2003) Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer\u2019s disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology 28:809\u2013822","journal-title":"Psychoneuroendocrinology"},{"key":"9296_CR43","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","volume":"24","author":"L Zhao","year":"2004","unstructured":"Zhao L, Teter B, Morihara T, Lim GP, Ambegaokar SS, Ubeda OJ, Frautschy SA, Cole GM (2004) Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer\u2019s disease intervention. J Neurosci 24:11120\u201311126","journal-title":"J Neurosci"},{"key":"9296_CR44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1006\/bbrc.1998.8186","volume":"243","author":"P Odetti","year":"1998","unstructured":"Odetti P, Angelini G, Dapino D, Zaccheo D, Garibaldi S, Dagna-Bricarelli F, Piombo G, Perry G, Smith M, Traverso N, Tabaton M (1998) Early glycoxidation damage in brains from Down\u2019s syndrome. Biochem Biophys Res Commun 243:849\u2013851","journal-title":"Biochem Biophys Res Commun"},{"key":"9296_CR45","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9440(10)64296-4","volume":"162","author":"AD Cash","year":"2003","unstructured":"Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, Avila J, Jones PK, Castellani RJ, Smith MA, Perry G (2003) Microtubule reduction in Alzheimer\u2019s disease and aging is independent of tau filament formation. Am J Pathol 162:1623\u20131627","journal-title":"Am J Pathol"},{"key":"9296_CR46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.jnen.0000205143.16339.cd","volume":"65","author":"EJ Dubelaar","year":"2006","unstructured":"Dubelaar EJ, Mufson EJ, ter Meulen WG, Van Heerikhuize JJ, Verwer RW, Swaab DF (2006) Increased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus. J Neuropathol Exp Neurol 65:257\u2013266","journal-title":"J Neuropathol Exp Neurol"},{"key":"9296_CR47","first-page":"65","volume":"162","author":"DG Munoz","year":"2000","unstructured":"Munoz DG, Feldman H (2000) Causes of Alzheimer\u2019s disease. CMAJ 162:65\u201372","journal-title":"CMAJ"},{"key":"9296_CR48","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.61.5.518","volume":"61","author":"AS Khachaturian","year":"2004","unstructured":"Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC (2004) Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache county study. Arch Gen Psychiatry 61:518\u2013524","journal-title":"Arch Gen Psychiatry"},{"key":"9296_CR49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","volume":"14","author":"M Miyata","year":"1996","unstructured":"Miyata M, Smith JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14:55\u201361","journal-title":"Nat Genet"},{"key":"9296_CR50","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","volume":"91","author":"WJ Strittmatter","year":"1994","unstructured":"Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci USA 91:11183\u201311186","journal-title":"Proc Natl Acad Sci USA"},{"key":"9296_CR51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00002093-200201000-00002","volume":"16","author":"DG Harwood","year":"2002","unstructured":"Harwood DG, Barker WW, Ownby RL, Mullan M, Duara R (2002) Apolipoprotein E polymorphism and cognitive impairment in a bi-ethnic community-dwelling elderly sample. Alzheimer Dis Assoc Disord 16:8\u201314","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"9296_CR52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(97)00624-1","volume":"233","author":"F Bellivier","year":"1997","unstructured":"Bellivier F, Laplanche JL, Schurhoff F, Feingold J, Feline A, Jouvent R, Launay JM, Leboyer M (1997) Apolipoprotein E gene polymorphism in early and late onset bipolar patients. Neurosci Lett 233:45\u201348","journal-title":"Neurosci Lett"},{"key":"9296_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s001270050017","volume":"33","author":"B Schmand","year":"1998","unstructured":"Schmand B, Hooijer C, Jonker C, Lindeboom J, Havekes LM (1998) Apolipoprotein E phenotype is not related to late-life depression in a population-based sample. Soc Psychiatry Psychiatr Epidemiol 33:21\u201326","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"9296_CR54","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/oxfordjournals.aje.a009711","volume":"148","author":"BV Howard","year":"1998","unstructured":"Howard BV, Gidding SS, Liu K (1998) Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 148:859\u2013868","journal-title":"Am J Epidemiol"},{"key":"9296_CR55","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(97)00015-2","volume":"41","author":"R Igata-Yi","year":"1997","unstructured":"Igata-Yi R, Igata T, Ishizuka K, Kimura T, Sakamoto S, Katsuragi S, Takamatsu J, Miyakawa T (1997) Apolipoprotein E genotype and psychosis. Biol Psychiatry 41:906\u2013908","journal-title":"Biol Psychiatry"},{"key":"9296_CR56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-2275(20)40051-3","volume":"36","author":"T Lehtimaki","year":"1995","unstructured":"Lehtimaki T, Moilanen T, Porkka K, Akerblom HK, Ronnemaa T, Rasanen L, Viikari J, Ehnholm C, Nikkari T (1995) Association between serum lipids and apolipoprotein E phenotype is influenced by diet in a population-based sample of free-living children and young adults: the Cardiovascular Risk in Young Finns Study. J Lipid Res 36:653\u2013661","journal-title":"J Lipid Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-007-9296-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-007-9296-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-007-9296-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T14:02:16Z","timestamp":1707660136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-007-9296-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,7]]},"references-count":56,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2007,3,22]]}},"alternative-id":["9296"],"URL":"https:\/\/doi.org\/10.1007\/s11064-007-9296-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,7]]}}}